Table 1.
Clinical characteristics and level of miR‐4286 and PTEN mRNA expression in NSCLC tissue
| Characteristics | n (%) | miR‐4286 mRNA expression | PTEN mRNA expression |
|---|---|---|---|
| Age | |||
| ≤65 | 20 (65%) | 91.72 ± 15.24 | 0.0438 ± 0.008847 |
| >65 | 11 (35%) | 106.2 ± 31.18 | 0.06136 ± 0.02409 |
| P value | 0.6427 | 0.417 | |
| Gender | |||
| Male | 17 (55%) | 72.11 ± 23.25 | 0.05606 ± 0.01552 |
| Female | 14 (45%) | 126.9 ± 12.1 | 0.04271 ± 0.01259 |
| P value | 0.0595 | 0.5218 | |
| Histology | |||
| Adenocarcinoma | 19 (61%) | 128.5 ± 16.92 | 0.05684 ± 0.01613 |
| Squamous cell carcinoma | 8 (26%) | 40.17 ± 26.46 | 0.0474 ± 0.006588 |
| Others | 4 (13%) | 59.71 ± 27.72 | 0.02294 ± 0.006263 |
| P value | 0.019 | 0.116 | |
| Smoking status | |||
| Yes | 15 (48%) | 80.4 ± 25.64 | 0.05872 ± 0.01753 |
| No | 16 (52%) | 112.3 ± 14.54 | 0.04188 ± 0.01101 |
| P value | 0.2809 | 0.4163 | |
| Clinical stage | |||
| I | 11 (35%) | 101.8 ± 24.36 | 0.03146 ± 0.004367 |
| II | 7 (23%) | 59.94 ± 25.62 | 0.03668 ± 0.006255 |
| III | 9 (29%) | 91.14 ± 29.23 | 0.05756 ± 0.01896 |
| IV | 4 (13%) | 160.5 ± 36.52 | 0.1075 ± 0.06286 |
| P value | 0.317 | 0.41 | |
| Lymph node metastasis | |||
| No | 14 (45%) | 104.6 ± 23.7 | 0.06971 ± 0.02124 |
| Yes | 17 (55%) | 90.48 ± 18.48 | 0.03382 ± 0.00375 |
| P value | 0.6375 | 0.0779 | |
Data are presented as mean ± SE. An unpaired t test was used for two groups. The Kruskal‐Wallis test was used for three or more groups. PTEN, phosphatase and tensin homologue deleted on chromosome 10.